跳至主要内容
临床试验/NCT07611890
NCT07611890招募中4 期

Comparison of Intravenous Dexmedetomidine and Lignocaine in Reducing Hemodynamic Responses During Laryngoscopy and Endotracheal Intubation In Patients Undergoing Cardiac Surgery at Rawalpindi Institute Of Cardiology- A Randomized Controlled Trial

Rawalpindi Institute of Cardiology1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年5月21日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
70
试验地点
1

研究概览

简要总结

After confirming eligibility, written informed consent will be obtained by a trained team member who is not involved in assigning treatment or giving the study medication. Each participant will receive a unique study number to protect privacy. Participants will be randomly assigned to receive one of the study medications using a chance-based method.The study medication will be administered through a vein before placement of the breathing tube. Blood pressure and pulse rate will be measured before the procedure and at several time points after the breathing tube is inserted.

详细描述

After confirming eligibility, written informed consent will be obtained and each participant will be assigned a unique study ID to maintain confidentiality. Participants will be randomly allocated using a computer-generated random sequence implemented through the lottery method, with assignments placed in sealed opaque envelopes opened on the day of surgery. The study medication will be administered intravenously according to the study protocol before laryngoscopy and endotracheal intubation. Mean arterial pressure and heart rate will be recorded at baseline and at 1, 3, 5, and 10 minutes after intubation. Demographic information and study-related observations will be documented in a structured data collection form.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status III-IV. Patients who are at risk of cardiovascular events

排除标准

  • Patients with known hypersensitivity to dexmedetomidine and Lignocaine.
  • Patients on medications that could interfere with the study (e.g., beta-blockers, calcium channel blockers).
  • Pregnant or lactating women.
  • Patients with a history of airway anomalies or difficult intubation.

研究者

发起方
Rawalpindi Institute of Cardiology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Namrah Zujaj

Principal Investigator

Rawalpindi Institute of Cardiology

研究点 (1)

Loading locations...

相似试验